Kui Cheng
- Molecular Biology top 10%
- Immunology top 5%
- Pharmacology top 1%
- Oncology top 10%
- Neurology top 2%
- Co-authors
- Hang YinXiaohui WangJohn B. SchenkmanXiaohong CenShuwen LiuKutty Selva NandakumarMarilyn KhannaBernard Moss
- Topics
- Immune Response and Inflammation (26 papers)Nanoplatforms for cancer theranostics (10 papers)NF-κB Signaling Pathways (9 papers)
- Journals
- Proceedings of the National Academy of SciencesJournal of the American Chemical SocietyJournal of Biological Chemistry
- Partner nations
- ChinaUnited StatesNorway
In The Last Decade
Kui Cheng
85 papers receiving 3.3k citations
Peers
Comparison fields: 5 of 126
- Molecular Biology 1.1k
- Immunology 856
- Pharmacology 392
- Oncology 358
- Neurology 350
Countries citing papers authored by Kui Cheng
This map shows the geographic impact of Kui Cheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kui Cheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kui Cheng more than expected).
Fields of papers citing papers by Kui Cheng
This network shows the impact of papers produced by Kui Cheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kui Cheng. The network helps show where Kui Cheng may publish in the future.
Co-authorship network of co-authors of Kui Cheng
This figure shows the co-authorship network connecting the top 25 collaborators of Kui Cheng. A scholar is included among the top collaborators of Kui Cheng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kui Cheng. Kui Cheng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 0 | |
| 3 | 4 | |
| 4 | 2 | |
| 5 | 5 | |
| 6 | 2 | |
| 7 | 0 | |
| 8 | 13 | |
| 9 | 14 | |
| 10 | 34 | |
| 11 | 49 | |
| 12 | 13 | |
| 13 | 16 | |
| 14 | 10 | |
| 15 | 49 | |
| 16 | 24 | |
| 17 | 28 | |
| 18 | 161 | |
| 19 | 21 | |
| 20 | 25 |
About Kui Cheng
Kui Cheng is a scholar working on Immunology, Pharmacology and Microbiology, having authored 92 papers that have together received 3.3k indexed citations. Recurring topics across this work include Immune Response and Inflammation (26 papers), Nanoplatforms for cancer theranostics (10 papers) and NF-κB Signaling Pathways (9 papers). The work is most often cited by research in Biological Psychiatry (126 citations), Pharmacology (392 citations) and Neurology (350 citations). Kui Cheng has collaborated with scholars based in China, United States and Norway. Frequent co-authors include Hang Yin, Xiaohui Wang, John B. Schenkman, Xiaohong Cen, Shuwen Liu, Kutty Selva Nandakumar, Marilyn Khanna, Bernard Moss, Kenan Qin and Shuting Zhang. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Journal of Biological Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.